Immune Pharmaceuticals, Inc. Stock OTC Markets
Stocks
IMNPQ
US45254C2008
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -23.08% |
| Manager | Title | Age | Since |
|---|---|---|---|
Devin J. Shaw
DFI | Director of Finance/CFO | 39 | 2021-04-12 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 2017-12-10 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Sidransky
BRD | Director/Board Member | 66 | 2013-08-25 |
Daniel Kazado
CHM | Chairman | 61 | 2013-10-09 |
John A. Neczesny
BRD | Director/Board Member | 62 | 2016-02-01 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 386K | |
| +0.85% | -0.80% | +52.79% | +159.97% | 1,051B | |
| +1.23% | -1.53% | +54.58% | +59.41% | 609B | |
| +0.04% | +2.58% | +34.47% | +84.84% | 450B | |
| -0.09% | +1.39% | +31.18% | +22.46% | 330B | |
| -0.70% | -0.06% | +35.99% | +36.89% | 284B | |
| -0.44% | -0.35% | +22.81% | +17.48% | 263B | |
| -0.05% | +1.86% | -19.58% | -40.15% | 223B | |
| -1.42% | +0.80% | +24.27% | +57.85% | 198B | |
| -1.48% | +3.43% | +24.08% | +70.06% | 167B | |
| Average | -0.27% | +0.54% | +28.95% | +52.09% | 397.23B | |
| Weighted average by Cap. | -0.14% | +0.02% | +37.82% | +78.09% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- FZRQ Stock
- IMNPQ Stock
Select your edition
All financial news and data tailored to specific country editions
